MX2019015007A - Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb. - Google Patents
Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb.Info
- Publication number
- MX2019015007A MX2019015007A MX2019015007A MX2019015007A MX2019015007A MX 2019015007 A MX2019015007 A MX 2019015007A MX 2019015007 A MX2019015007 A MX 2019015007A MX 2019015007 A MX2019015007 A MX 2019015007A MX 2019015007 A MX2019015007 A MX 2019015007A
- Authority
- MX
- Mexico
- Prior art keywords
- immunogenic compositions
- staphylococcus aureus
- lukb
- luka
- derived polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente descripción proporciona composiciones inmunogénicas útiles en la prevención y el tratamiento de infecciones por Staphylococcus aureus. En particular, la descripción proporciona métodos para inducir una respuesta inmunitaria contra un S. aureus que expresa LukAB, métodos para prevenir o tratar infecciones por S. aureus y una composición para prevenir o tratar infecciones por S. aureus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762518641P | 2017-06-13 | 2017-06-13 | |
PCT/US2018/037376 WO2018232014A1 (en) | 2017-06-13 | 2018-06-13 | Immunogenic compositions comprising staphylococcus aureus leukocidin luka and lukb derived polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019015007A true MX2019015007A (es) | 2020-08-06 |
Family
ID=64660858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019015007A MX2019015007A (es) | 2017-06-13 | 2018-06-13 | Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb. |
Country Status (7)
Country | Link |
---|---|
US (1) | US11421021B2 (es) |
EP (1) | EP3638286A4 (es) |
CN (1) | CN110913883A (es) |
AU (1) | AU2018285857B2 (es) |
CA (1) | CA3066450A1 (es) |
MX (1) | MX2019015007A (es) |
WO (1) | WO2018232014A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3155424A1 (en) | 2019-10-02 | 2021-04-08 | Janssen Vaccines & Prevention B.V. | Staphylococcus peptides and methods of use |
CA3195895A1 (en) * | 2020-09-28 | 2022-03-31 | Janssen Pharmaceuticals, Inc. | Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions |
CA3215751A1 (en) * | 2021-04-02 | 2022-10-06 | Janssen Pharmaceuticals, Inc. | Staphylococcus aureus vaccine compositions |
CN116078360B (zh) * | 2023-03-07 | 2023-06-23 | 佛山市博新生物科技有限公司 | 一种清除白细胞及致病抗体的吸附纤维膜及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US20050008633A1 (en) | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
BR112012029521A2 (pt) * | 2010-05-05 | 2018-03-06 | New York University | leucocidinas do staphylococcus aureus, composições terapêuticas, e aplicações das mesmas. |
PL2668208T3 (pl) | 2012-04-17 | 2015-12-31 | Arsanis Biosciences Gmbh | Krzyżowo reaktywne przeciwciało rozpoznające Staphylococcus aureus |
CA2871152A1 (en) * | 2012-05-02 | 2013-11-07 | New York University | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
JP6560195B2 (ja) * | 2013-05-21 | 2019-08-14 | アルサニス・バイオサイエンスズ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 黄色ブドウ球菌のLukGH(LukAB)毒素を中和する、非常に強力な抗体の生成 |
CA2931327A1 (en) | 2013-12-19 | 2015-06-25 | Arsanis Biosciences Gmbh | Antibodies directed against the lukgh (lukab) toxin of staphylococcus aureus and antibody sequences |
JP2018517708A (ja) * | 2015-06-05 | 2018-07-05 | ニューヨーク・ユニバーシティ | 抗ブドウ球菌生物学的薬剤のための組成物及び方法 |
-
2018
- 2018-06-13 MX MX2019015007A patent/MX2019015007A/es unknown
- 2018-06-13 US US16/621,444 patent/US11421021B2/en active Active
- 2018-06-13 CN CN201880046208.3A patent/CN110913883A/zh active Pending
- 2018-06-13 AU AU2018285857A patent/AU2018285857B2/en active Active
- 2018-06-13 EP EP18816775.3A patent/EP3638286A4/en active Pending
- 2018-06-13 CA CA3066450A patent/CA3066450A1/en active Pending
- 2018-06-13 WO PCT/US2018/037376 patent/WO2018232014A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3066450A1 (en) | 2018-12-20 |
US20200317759A1 (en) | 2020-10-08 |
US11421021B2 (en) | 2022-08-23 |
EP3638286A4 (en) | 2021-03-10 |
CN110913883A (zh) | 2020-03-24 |
AU2018285857A1 (en) | 2020-01-02 |
WO2018232014A1 (en) | 2018-12-20 |
EP3638286A1 (en) | 2020-04-22 |
AU2018285857B2 (en) | 2022-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023003461A (es) | Tratamiento de infeccion por clostridium difficile. | |
MX2023013140A (es) | Vacunas contra el virus de la hepatitis b. | |
MX2022006525A (es) | Activo de polipeptidos de lisina contra bacterias gram-negativas. | |
WO2015181356A8 (en) | Vaccine composition against streptococcus suis infection | |
WO2016179440A3 (en) | Antimicrobial therapy | |
MX2019015007A (es) | Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb. | |
WO2016109689A3 (en) | Derivatives and methods of treating hepatitis b infections | |
WO2016108045A3 (en) | Antimicrobial compounds, compositions and methods | |
PH12020500080A1 (en) | Senecavirus a immunogenic compositions and methods thereof | |
WO2015110969A3 (en) | Nitrogen containing compounds and their use as antibacterial agents | |
PH12016502003A1 (en) | Novel bacteriophage and composition containing same | |
WO2016004513A8 (en) | Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods | |
MX2021002719A (es) | Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos. | |
WO2017075188A3 (en) | Methods of using anti-alpha toxin antibody | |
MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
MX2021002909A (es) | Vacunas de proteinas de fusion neumococicas. | |
MX2018001512A (es) | Composiciones antimicrobianas que comprenden mupirocina y neomicina. | |
MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
PH12019502915A1 (en) | Immunogenic compositions | |
MY183483A (en) | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof | |
PH12019502145A1 (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | |
MX2021013833A (es) | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). | |
WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections | |
WO2016072854A3 (en) | Pantothenamide analogues | |
AU2018272839A8 (en) | Fractionated antimicrobial compositions and use thereof |